BIOLOGICAL, SEROLOGICAL, AND GENETIC-CHARACTERIZATION OF HIV-1 SUBTYPE-E ISOLATES FROM NORTHERN THAILAND

被引:43
作者
ICHIMURA, H
KLIKS, SC
VISRUTARATNA, S
OU, CY
KALISH, ML
LEVY, JA
机构
[1] UNIV CALIF SAN FRANCISCO,SCH MED,CANC RES INST,DEPT MED,SAN FRANCISCO,CA 94143
[2] MINIST PUBL HLTH,CHIANGMAI PROV HLTH OFF,CHIANG MAI,THAILAND
[3] CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV HIV AIDS,ATLANTA,GA 30333
关键词
D O I
10.1089/aid.1994.10.263
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Twenty-three HIV-1 isolates were recovered from PBMCs from 26 HIV-1-seropositive individuals in northern Thailand. The viruses grew readily in human PBMCs but only 7 of 17 (41.2%) and 5 of 17 (29.4%) replicated and only at a low level in primary macrophages and in established T cell lines, respectively. By immunoblot assays, sera from Thai subjects were strongly reactive with gp120 from a Thailand isolate, moderately reactive with a Rwandan isolate, and weakly reactive with a North American strain. These three viruses represent, respectively, examples of subtypes E, A, and B as classified by the sequences of the envelope region.(1) Serological assays indicated that broadly reactive rather than type-specific neutralizing activity was detected among these northern Thai sera. The majority of the sera (approximately 75%) neutralized a representative Thailand isolate and the Rwanda isolate but only 55% neutralized the North American strain. However, the difference was not statistically significant. The genetic analyses indicated that nearly all the Thai isolates were highly homogeneous and distinct from the North American/European consensus sequence (subtype B); they belong to subtype E. This if the first report providing biological, serological, and genetic characterization of HIV-1 strains from Thailand. The findings suggest these viruses were recently introduced into the country and that serological evaluation of viral strains needs to be considered along with genetic subtyping when developing an HIV-1 vaccine.
引用
收藏
页码:263 / 269
页数:7
相关论文
共 26 条
[1]
OPTIMAL CONDITIONS FOR RECOVERY OF THE HUMAN IMMUNODEFICIENCY VIRUS FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
CASTRO, BA ;
WEISS, CD ;
WIVIOTT, LD ;
LEVY, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (11) :2371-2376
[2]
BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST [J].
CHENGMAYER, C ;
SETO, D ;
TATENO, M ;
LEVY, JA .
SCIENCE, 1988, 240 (4848) :80-82
[3]
IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS SUBTYPES WITH DISTINCT PATTERNS OF SENSITIVITY TO SERUM NEUTRALIZATION [J].
CHENGMAYER, C ;
HOMSY, J ;
EVANS, LA ;
LEVY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2815-2819
[4]
ISOLATES OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 FROM THE BRAIN MAY CONSTITUTE A SPECIAL GROUP OF THE AIDS VIRUS [J].
CHENGMAYER, C ;
WEISS, C ;
SETO, D ;
LEVY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8575-8579
[5]
CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM CHILDREN IN ROMANIA - IDENTIFICATION OF A NEW ENVELOPE SUBTYPE [J].
DUMITRESCU, O ;
KALISH, ML ;
KLIKS, SC ;
BANDEA, CI ;
LEVY, JA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :281-288
[6]
MULTIPLE ALIGNED SEQUENCE EDITOR (MASE) [J].
FAULKNER, DV ;
JURKA, J .
TRENDS IN BIOCHEMICAL SCIENCES, 1988, 13 (08) :321-322
[7]
FELSENTEIEN J, 1993, PHYLIP PHYLOGENY INT
[8]
THE ROLE OF MONONUCLEAR PHAGOCYTES IN HTLV-III LAV INFECTION [J].
GARTNER, S ;
MARKOVITS, P ;
MARKOVITZ, DM ;
KAPLAN, MH ;
GALLO, RC ;
POPOVIC, M .
SCIENCE, 1986, 233 (4760) :215-219
[9]
SYNTHETIC PEPTIDE IMMUNOASSAY DISTINGUISHES HIV TYPE-1 AND HIV TYPE-2 INFECTIONS [J].
GNANN, JW ;
MCCORMICK, JB ;
MITCHELL, S ;
NELSON, JA ;
OLDSTONE, MBA .
SCIENCE, 1987, 237 (4820) :1346-1349
[10]
NEUTRALIZATION OF DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS BY AN ANTI-V3 HUMAN MONOCLONAL-ANTIBODY [J].
GORNY, MK ;
CONLEY, AJ ;
KARWOWSKA, S ;
BUCHBINDER, A ;
XU, JY ;
EMINI, EA ;
KOENIG, S ;
ZOLLAPAZNER, S .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7538-7542